Replies to post #22578 on MannKind Corp. (MNKD)

[TREND1]

read the FDA report that comes with every order of AFREZZA.
AFREZZA is not better than rapid acting insulin.

[kugel]

What is amazing is the knowledge and hard work and years put into a great product,can be ruined by lowlife hedge funds big pharma negative posts and ads..hope we make it out of this and see those prosecuted that are responsible..Looks like a group of people are getting together that might be able to bring some change..IMHO

[DownWithPumpers]

The article refutes what you said about Afrezza not being more effective for mealtime insulin. I don't have the time to respond to all your imaginary interpretations of known facts.

This is the complete study: http://www.mannkindcorp.com/assets/Heinmann-JDiabSciTech-2017.pdf

You think it's more effective because it's fact acting. Mannkind reports that 38% of patients need an extra dose because it doesn't last long enough.